Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR000448, subaward KL2TR000450, UL1 TR002345, KL2TR002346)
National Institute of Diabetes and Digestive and Kidney Diseases (1P30DK092950 (pilot))
Agency for Healthcare Research and Quality (R24 HS19455)
National Cancer Institute (KM1CA156708)
Received: 22 November 2018
Accepted: 24 January 2019
First Online: 4 February 2019
Ethics approval and consent to participate
: Our study protocol number 201510005 was reviewed and approved with a partial HIPAA waiver by the Washington University Human Research Protection Office on October 1, 2015 with last continuing review completed on July 3, 2018.
: Not applicable.
: MRK, AMT and GAC have no competing interests to report. CJH received an honorarium for speaking at the annual meeting of the MPCA on October 26, 2018. MAO receives grant funding and provides consultation services for Pfizer and Sanofi Pasteur and serves on an Advisory Board for Pfizer. BPC is currently employed by Centene Corporation but was previously employed by the Public Health Data and Training Center at Washington University.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.